Privacy preference

MEDtalks would like to keep you informed about the content that is most relevant to you. Click here for more information.


TIMM 2019: mucormycosis

Anna Skiada, MD, PhD brings you up to speed on the developments on management of mucormycosis, like recent guideline updates. Also, she talks about the importance of registries for mucormycosis to get more knowledge about this potential lethal disease.

  • Invited speakers

  • Anna Skiada, MD, PhD

    Internist (infectious diseases)

    Laiko Hospital, National and Kapodistrian University of Athens, Greece

  • Sponsors

    This program is editorially independent and is financially supported by:

Related items

Congress news 19/11/2019

TIMM 2019: influenza-associated aspergillosis

Influenza-associated aspergillosis is a difficult problem for critically ill ICU patients. Bart Rijnders, MD, PhD, was eager to share some insights on epidemiology, etiology and management of influenza-associated aspergillosis. Moreover he elaborates on endeavors to improve outcome for these patients (e.g. research and the development of guidelines).

Congress news 19/11/2019

TIMM 2019: paediatric invasive fungal infections

Chairwoman prof. Adilia Warris, MD, PhD, elaborates on the goals of the European Peadiatric Mycology Network to improve the management of invasive fungal infections. Furthermore, she shares new insights on epidemiology, diagnostic tests and treatment of invasive fungal infections in children.

Congress news 19/11/2019

TIMM 2019: azole resistant invasive aspergillosis

One of the major challenges in the management of invasive aspergillosis is resistance against azoles. For this reason, prof. Paul Verweij, MD, PhD, expands on this subject. He will share details on the current epidemiology of azole resistance and explains how antifungal stewardship can help to control the increase of resistance.

Congress news 19/11/2019

Highlights of the Trends in Medical Mycology 2019

From October 11th until the 14th, the 9th edition of the Trends in Medical Mycology has been held in Nice, France. Since conferences run parallel sessions, it is impossible to acquire every bit of information. As we still face several difficulties in the management of potential lethal invasive fungal diseases, this might just as well be life saving information. Therefore, MEDtalks traveled to Nice to interview renowned experts to bring you up to speed on developments that impact clinical practice. Speakers & topics Prof. Adilia Warris, MD, PhD Management of invasive fungal infections in paediatrics - what is new? Prof. Paul Verweij, MD, PhD Stewardship and azole resistant aspergillosis: a challenge for farmer or physician? Bart Rijnders, MD, PhD Aspergillus in the ICU: influenza-associated aspergillosis Anna Skiada, MD, PhD Management of mucormycosis - what is new?

Congress news 30/04/2019

ECCMID 2019

From April 13th - 16th, Amsterdam hosted the 29th European Congress of Clinical Microbiology & Infectious Diseases. With thousands of abstracts being discussed, it was easy to miss out on some developments. Invasive fungal diseases still pose many diagnostic and therapeutic challenges. Therefore, MEDtalks asked several top experts to come up with their personal (congress) highlights regarding this challenging topic, and focus on translating scientific developments to clinical practice. Topics and speakers Impact of new immunomodulators on the risk and management of invasive fungal infections by prof. Dimitrios Kontoyiannis, MD, PhD Management of invasive fungal infections by prof. Johan Maertens, MD, PhD New ESCMID guideline on invasive fungal infections by prof. Cornelia Lass-Flörl, MD, PhD The diagnosis of invasive fungal infections by prof. Katrien Lagrou, PharmD, PhD  

Congress news 25/04/2019

ECCMID 2019: the diagnosis of invasive fungal infections

Invasive fungal diseases still pose many diagnostic challenges. MEDtalks asked prof. Katrien Lagrou to elaborate on some challenges that particularly concerned her, and to scour the ECCMID 2019 program for interesting (future) diagnostic developments.   This editorially independent interview has been financially sponsored by Gilead.

Congress news 25/04/2019

ECCMID 2019: management of invasive fungal infections

Managing invasive fungal diseases is a dynamic expertise. In this interview, prof. Johan Maertens talks about the changing fungal landscape, both in terms of the host (i.e. haematological patients) as the type of fungal pathogen. Looking at these changes: what are the relevant challenges and therapeutic opportunities?   This editorially independent interview has been financially sponsored by Gilead.

Congress news 25/04/2019

ECCMID 2019: immunomodulators and invasive fungal infections

Oncology treatment has come a long way. Prof. Dimitrios Kontoyiannis first discusses the recent changes in oncology treatment and their respective impact on the risk of invasive fungal infections. Then he adresses which emerging patient populations in the (hemato-)oncology setting are at an increased risk of infections. How do we properly identify them and what are the challenges in treatment of these patients?   This editorially independent interview has been financially sponsored by Gilead.